ストックスクリーナーアプリを入手
3.55
3.27%
-0.12
アフターアワーズ：
3.55
前日終値:
$3.67
開ける：
$3.63
24時間の取引高:
3.32M
Relative Volume:
0.43
時価総額：
$604.50M
収益：
-
当期純損益:
$-37.34M
株価収益率:
-2.6103
EPS:
-1.36
ネットキャッシュフロー:
$-36.91M
1週間 パフォーマンス:
+0.57%
1か月 パフォーマンス:
-13.63%
6か月 パフォーマンス:
+120.50%
1年 パフォーマンス:
+170.99%
1日の値動き範囲:
$3.46
$3.6884
1週間の範囲:
$3.46
$3.90
52週間の値動き範囲:
$0.9516
$5.1765
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
名前
Sellas Life Sciences Group Inc
セクター
電話
(646) 200-5278
住所
7 TIMES SQUARE, NEW YORK, NY
Compare SLS vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
3.55 | 624.94M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-01 | 開始されました | Oppenheimer | Outperform |
| 2018-04-02 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | アップグレード | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc (SLS) 最新ニュース
Sentiment Recap: Can SELLAS Life Sciences Group Inc beat the S P 500Dip Buying & Short-Term High Return Ideas - baoquankhu1.vn
Surprises Report: Is Freeport McMoRan Incs growth already priced inQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
Market Review: How correlated is SPKLU to the S P5002025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Forecast Cut: Does SELLAS Life Sciences Group Inc align with a passive investing strategyMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Pharma News: Can SELLAS Life Sciences Group Inc stock double in the next year2025 Key Highlights & Community Consensus Picks - baoquankhu1.vn
Aug Ideas: Should I hold or sell SELLAS Life Sciences Group Inc nowBull Run & AI Optimized Trade Strategies - baoquankhu1.vn
Can SELLAS Life Sciences Group Inc beat the S P 5002025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Can SELLAS Life Sciences Group Inc. stock double in the next yearRate Cut & Low Volatility Stock Recommendations - mfd.ru
SLS Stock Nears 52-Week High Amid Market Turbulence: What It Means for Investors - StocksToTrade
Sellas Life Sciences Rallies as REGAL Debate Drives Momentum Toward 52-Week High - timothysykes.com
Heightened Volatility Marks Sellas Life Sciences as Key Clinical Milestones Approach - AD HOC NEWS
SLS Stock Price, Forecast & Analysis | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - Chartmill
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Rises as Traders Weigh REGAL Debate and Microcap Volatility - StocksToTrade
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS) - Seeking Alpha
Will SELLAS Life Sciences Group Inc. stock see PE expansion2025 Pullback Review & Proven Capital Preservation Methods - bollywoodhelpline.com
Sellas Life Sciences Shares Surge with Strategic Clinical Study Moves - StocksToTrade
SELLAS Life Sciences’ European Partnership Spurs Market Optimism - timothysykes.com
Key Developments in SLS’s Market Strategy - StocksToTrade
SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st
Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade
Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe - Sahm
SELLAS partners with IMPACT-AML for European SLS009 trials By Investing.com - Investing.com Nigeria
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement - Yahoo Finance
How SELLAS’s IMPACT-AML Trial Expansion At SELLAS Life Sciences Group (SLS) Has Changed Its Investment Story - simplywall.st
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout - Asianet Newsable
SELLAS partners with IMPACT-AML for European SLS009 trials - Investing.com
Sellas Life Sciences, Impact-AML Collaborate on EU Trial of SLS009 in Acute Myeloid Leukemia - marketscreener.com
Aug Fed Impact: Is CACC trading at a discountVolume Spike & Fast Moving Stock Trade Plans - baoquankhu1.vn
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 REGAL Trial Progress - Quiver Quantitative
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Up 10.3%Here's What Happened - MarketBeat
Sellas Life Sciences Jumps in Volatile Session After Recent Selloff - StocksToTrade
Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat
Sellas Life Sciences Rebounds After Volatile Selloff - timothysykes.com
Sellas Life Sciences Stock Slides as Trading Dynamics Overshadow Trial Timeline Update - StocksToTrade
Published on: 2026-01-10 22:25:31 - Улправда
SELLAS Stock Dips Amid Volatility After Warrant Exercise Update - StocksToTrade
Sellas Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? - Asianet Newsable
SLS Stock Slides Amid Volatility as Traders Focus on Dilution Concerns - timothysykes.com
SELLAS Life Sciences Falls For Fourth Straight SessionWhat's Driving The Sell Off? - Menafn
Sellas Life Sciences Group Inc (SLS) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):